Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

TGF-β3 controls stem cell growth and development, varying by cell type and conditions.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Sentinel lymph node biopsy is recommended for all types of desmoplastic melanoma due to higher rates of nodal metastasis.

Sentinel lymph node biopsy is recommended for all types of desmoplastic melanoma due to higher rates of nodal metastasis.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Careful diagnosis and management of MCTD are crucial due to potential severe complications.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

The document concludes that Passiflora incarnata could help with anxiety, telemedicine might improve heart failure care, screen time for kids has increased, pregnant teens in Brazil are mostly okay with their body image, rare tuberculosis infection can occur after knee surgery, older and severely ill people are more likely to have long COVID-19 symptoms, HPLC might diagnose more diabetes cases, and psychiatrists should be involved in pain management.

Diabetes can cause hair thinning, increased hair loss, and changes in hair growth phases.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Suppressing ODC activity reduces tumor growth in hair follicles.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

MAD2B slows down the growth of skin cells that are important for hair development by interacting with TCF4.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.